vs

Side-by-side financial comparison of MEDIFAST INC (MED) and OCEANFIRST FINANCIAL CORP (OCFC). Click either name above to swap in a different company.

OCEANFIRST FINANCIAL CORP is the larger business by last-quarter revenue ($104.7M vs $75.1M, roughly 1.4× MEDIFAST INC). On growth, OCEANFIRST FINANCIAL CORP posted the faster year-over-year revenue change (9.6% vs -36.9%). OCEANFIRST FINANCIAL CORP produced more free cash flow last quarter ($79.5M vs $-6.6M). Over the past eight quarters, OCEANFIRST FINANCIAL CORP's revenue compounded faster (3.1% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

OceanFirst Bank N.A. is an American regional bank subsidiary of the U.S. financial services holding company OceanFirst Financial Corp. founded and headquartered in Ocean County, New Jersey, with operations throughout New Jersey, and in the major metropolitan markets of Philadelphia, New York City, Baltimore, Boston, Washington D.C.

MED vs OCFC — Head-to-Head

Bigger by revenue
OCFC
OCFC
1.4× larger
OCFC
$104.7M
$75.1M
MED
Growing faster (revenue YoY)
OCFC
OCFC
+46.4% gap
OCFC
9.6%
-36.9%
MED
More free cash flow
OCFC
OCFC
$86.1M more FCF
OCFC
$79.5M
$-6.6M
MED
Faster 2-yr revenue CAGR
OCFC
OCFC
Annualised
OCFC
3.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
OCFC
OCFC
Revenue
$75.1M
$104.7M
Net Profit
$13.1M
Gross Margin
69.4%
Operating Margin
-10.4%
16.1%
Net Margin
12.5%
Revenue YoY
-36.9%
9.6%
Net Profit YoY
-40.2%
EPS (diluted)
$-1.64
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
OCFC
OCFC
Q4 25
$75.1M
$104.7M
Q3 25
$89.4M
$103.0M
Q2 25
$105.6M
$99.4M
Q1 25
$115.7M
$97.9M
Q4 24
$119.0M
$95.6M
Q3 24
$140.2M
$96.9M
Q2 24
$168.6M
$93.2M
Q1 24
$174.7M
$98.5M
Net Profit
MED
MED
OCFC
OCFC
Q4 25
$13.1M
Q3 25
$-2.3M
$17.3M
Q2 25
$2.5M
$19.0M
Q1 25
$-772.0K
$21.5M
Q4 24
$21.9M
Q3 24
$1.1M
$25.1M
Q2 24
$-8.2M
$24.4M
Q1 24
$8.3M
$28.7M
Gross Margin
MED
MED
OCFC
OCFC
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
OCFC
OCFC
Q4 25
-10.4%
16.1%
Q3 25
-4.6%
21.9%
Q2 25
-1.0%
25.0%
Q1 25
-1.1%
28.9%
Q4 24
0.6%
28.5%
Q3 24
1.5%
33.7%
Q2 24
-4.7%
33.8%
Q1 24
4.5%
39.8%
Net Margin
MED
MED
OCFC
OCFC
Q4 25
12.5%
Q3 25
-2.5%
16.8%
Q2 25
2.3%
19.2%
Q1 25
-0.7%
22.0%
Q4 24
22.9%
Q3 24
0.8%
25.9%
Q2 24
-4.8%
26.1%
Q1 24
4.8%
29.1%
EPS (diluted)
MED
MED
OCFC
OCFC
Q4 25
$-1.64
$0.24
Q3 25
$-0.21
$0.30
Q2 25
$0.22
$0.28
Q1 25
$-0.07
$0.35
Q4 24
$0.08
$0.36
Q3 24
$0.10
$0.42
Q2 24
$-0.75
$0.40
Q1 24
$0.76
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
OCFC
OCFC
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
$255.2M
Stockholders' EquityBook value
$198.9M
$1.7B
Total Assets
$248.0M
$14.6B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
OCFC
OCFC
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Total Debt
MED
MED
OCFC
OCFC
Q4 25
$255.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MED
MED
OCFC
OCFC
Q4 25
$198.9M
$1.7B
Q3 25
$214.7M
$1.7B
Q2 25
$216.0M
$1.6B
Q1 25
$211.0M
$1.7B
Q4 24
$210.1M
$1.7B
Q3 24
$207.3M
$1.7B
Q2 24
$205.3M
$1.7B
Q1 24
$211.0M
$1.7B
Total Assets
MED
MED
OCFC
OCFC
Q4 25
$248.0M
$14.6B
Q3 25
$268.2M
$14.3B
Q2 25
$269.3M
$13.3B
Q1 25
$280.0M
$13.3B
Q4 24
$284.2M
$13.4B
Q3 24
$291.2M
$13.5B
Q2 24
$293.5M
$13.3B
Q1 24
$302.8M
$13.4B
Debt / Equity
MED
MED
OCFC
OCFC
Q4 25
0.15×
Q3 25
Q2 25
Q1 25
Q4 24
0.12×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
OCFC
OCFC
Operating Cash FlowLast quarter
$-5.3M
$87.2M
Free Cash FlowOCF − Capex
$-6.6M
$79.5M
FCF MarginFCF / Revenue
-8.8%
75.9%
Capex IntensityCapex / Revenue
1.8%
7.4%
Cash ConversionOCF / Net Profit
6.66×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$125.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
OCFC
OCFC
Q4 25
$-5.3M
$87.2M
Q3 25
$12.1M
$24.4M
Q2 25
$-3.4M
$28.6M
Q1 25
$3.4M
$-1.8M
Q4 24
$-4.9M
$92.2M
Q3 24
$9.1M
$-22.4M
Q2 24
$13.1M
$23.7M
Q1 24
$7.3M
$46.1M
Free Cash Flow
MED
MED
OCFC
OCFC
Q4 25
$-6.6M
$79.5M
Q3 25
$10.8M
$22.8M
Q2 25
$-4.8M
$27.2M
Q1 25
$1.9M
$-3.6M
Q4 24
$-7.2M
$84.7M
Q3 24
$7.7M
$-23.5M
Q2 24
$11.1M
$19.5M
Q1 24
$5.4M
$45.4M
FCF Margin
MED
MED
OCFC
OCFC
Q4 25
-8.8%
75.9%
Q3 25
12.0%
22.2%
Q2 25
-4.5%
27.4%
Q1 25
1.6%
-3.7%
Q4 24
-6.1%
88.6%
Q3 24
5.5%
-24.2%
Q2 24
6.6%
20.9%
Q1 24
3.1%
46.1%
Capex Intensity
MED
MED
OCFC
OCFC
Q4 25
1.8%
7.4%
Q3 25
1.5%
1.5%
Q2 25
1.3%
1.4%
Q1 25
1.3%
1.9%
Q4 24
1.9%
7.9%
Q3 24
1.0%
1.1%
Q2 24
1.1%
4.5%
Q1 24
1.1%
0.7%
Cash Conversion
MED
MED
OCFC
OCFC
Q4 25
6.66×
Q3 25
1.41×
Q2 25
-1.36×
1.50×
Q1 25
-0.08×
Q4 24
4.21×
Q3 24
8.04×
-0.89×
Q2 24
0.97×
Q1 24
0.88×
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons